Skip to content

Clinical trials

Phase 2 Hyperthyroidism trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperthyroidism Phase: Phase 2 Country / region: United States Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20161
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen1
Immunovant Sciences GmbH1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Northwell Health1
Novartis Pharmaceuticals1
Tourmaline Bio, Inc., a Novartis Company1
University of Florida1
Yarrow Bioscience, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperthyroidism8
Graves Disease7
Exophthalmos1
Eye Diseases1
Graves Ophthalmopathy1
Hypothyroidism1
Neoplasms1
Thyroid Diseases1
Thyroid Neoplasms1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.